8-K
ABVC BioPharma Closes $3.39 Million Private Placement of Convertible Promissory Notes
8-K
ABVC BioPharma Completes Partial Spin-Off of BioKey (Cayman), Inc.
8-K/A
Distribution of BioKey Shares Postponed to August 21, 2026, for Administrative and Regulatory Completion
8-K
ABVC BioPharma Postpones Distribution of BioKey (Cayman), Inc. Shares
8-K
ABVC BioPharma, Inc. Announces Change of Independent Registered Public Accounting Firm
8-K
ABVC BioPharma, Inc. Announces Results of 2026 Annual Meeting of Shareholders
